| |||||||||
Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Background Strain C57BL/6 Donor Strain 129P2 via E14TG2a ES cell line Generation N?+3 Donating Investigator Shimon Efrat, Sackler School of Medicine Description
Glucokinase catalyzes a rate-limiting step in glucose metabolism in hepatocytes and pancreatic beta cells and is considered the "glucose sensor" for regulation of insulin secretion. Patients with maturity-onset diabetes of the young (MODY) have heterozygous point mutations in the glucokinase gene that result in reduced enzymatic activity and decreased insulin secretion. Disruption of the glucokinase gene results in a phenotype similar to MODY in heterozygous mice. These mice manifest a decreased insulin secretory response to glucose.
Strains carrying other alleles of Gck
003264 B6.129S7-Gcktm1Ts/J View Strains carrying other alleles of Gck (1 strain)
Congenic Nomenclature
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms
Maturity-Onset Diabetes of the Young, Type II; MODY2 - Models with phenotypic similarity to human disease where etiologies involve orthologs.1
1 Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Gcktm1Efr/Gck+
involves: 129P2/OlaHsd * C57BL/6
- homeostasis/metabolism phenotype
- abnormal glucose homeostasis (MGI Ref ID J:28756)
- heterozygotes exhibit abnormal hepatic glucose metabolism: hyperglycemia and hyperinsulinemia reduce hepatic glucose production by only 47% vs 72% in wild-type mice
- also, the fraction of hepatic UDPG pool derived from plasma glucose via the "direct" pathway is significantly reduced relative to wild-type
- hyperglycemia (MGI Ref ID J:28756)
- at 5-6 months, heterozygous males show normoglycemia in the fed state
- however, heterozygotes show a mild (25%) increase in overnight fasting glucose levels relative to wild-type mice
- in contrast, plasma insulin levels remain unchanged relative to wild-type in both the fed and fasted state
- impaired glucose tolerance (MGI Ref ID J:28756)
- heterozygotes display reduced tolerance to glucose relative to wild-type mice
Gcktm1Efr/Gcktm1Efr
involves: 129P2/OlaHsd * C57BL/6
- lethality-prenatal/perinatal
- embryonic lethality during organogenesis (MGI Ref ID J:28756)
- ~1/3 of mutant embryos are resorbed starting at E9.5
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Gcktm1Efr related
Developmental Biology Research
Postnatal Mortality (Homozygous)
Diabetes and Obesity Research
Hyperglycemia
Hypoinsulinemia
Type 2 Diabetes (NIDDM)
Endocrine Deficiency Research
Pancreas Defects
| Allele Symbol | Gcktm1Efr | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Shimon Efrat | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | GK-; | ||
| Mutation Made By | Shimon Efrat, Sackler School of Medicine | ||
| Strain of Origin | 129P2/OlaHsd | ||
| ES Cell Line Name | E14 | ||
| ES Cell Line Strain | 129P2/OlaHsd | ||
| Gene Symbol and Name | Gck, glucokinase | ||
| Chromosome | 11 | ||
| Gene Common Name(s) | GK; GLK; GLUKA; HHF3; HK4; HKIV; HXKP; MODY2; RNGK2; hexokinase 4; | ||
| Molecular Note | A fragment of the gene spanning exon 2 was replaced by a neomycin resistance cassette, resulting in a deletion and a frame shift of the transcript. Mice heterozygous for the targeted mutation had a 37% reduction in glucose phosphorylation activity in islet homogenates and a 28% reduction of activity in liver compared with wild-type littermates. [MGI Ref ID J:28756] | ||
Genotyping Protocols
NEOTD (Generic Neo), STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Bali D; Svetlanov A; Lee HW; Fusco-DeMane D; Leiser M; Li B; Barzilai N; Surana M; Hou H; Fleischer N; DePinho R; Rossetti L; Efrat S. 1995. Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. J Biol Chem 270(37):21464-7. [PubMed: 7665557] [MGI Ref ID J:28756]
Currently there no information available for this strain. This may be due to the supply level of this strain.
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.